English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduQuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) announced today that its subsidiary, Ortho Clinical Diagnostics, a leading provider of in vitro diagnostics solutions and services to hospitals, clinical laboratories and blood banks around the world, has earned the No. 1 ranking in the diagnostics industry for Overall Customer Satisfaction in the 2022 IMV ServiceTrak™ Awards for the fifth consecutive year. The ranking is based on interviews conducted with laboratory professionals, including Ortho’s customers, from more than 1,200 clinical testing locations operating over 1,900 collective instruments. The prestigious annual IMV ServiceTrak™ Awards rankings affirm the continued power and impact of Ortho’s innovative Ortho Care® Services and Informatics platform.
Tag: 2022 AACC Annual Scientific Meeting & Clinical Lab Expo
Athens Research and Technology, Inc. recognized as Exporter of the Year
The Georgia Department of Economic Development announced the winners of their annual Globe Awards on May 23rd, 2022. Among the awards were three top designations for Exporter of the Year. Athens Research and Technology, Inc. (ART) was the recipient of the Exporter of the Year award for a business with less than 20 employees. The award was presented at the laboratory to ART’s CEO, John Mitchell, on May 25th by Mary Waters, the Deputy Commissioner of International Trade for the State of Georgia.
Innovative Smartphone and Artificial Intelligence-Based Tests Featured at the 2022 AACC Annual Scientific Meeting
Scientists have developed a cheap, convenient smartphone test for monitoring patients at risk for dangerous blood clots. Research demonstrating that this test works, along with a second study on using artificial intelligence (AI) to improve testing and treatment for people with kidney stones, will be presented at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo. Both studies could help resolve longstanding challenges in healthcare and laboratory testing.
New Tests That Could Solve Persistent Challenges in Children’s Healthcare Presented at the 2022 AACC Annual Scientific Meeting
A first-of-its-kind test could make it easier for newborns to get care for spinal muscular atrophy, a common genetic disease that is life-threatening but treatable if caught in time. Findings on this method and a second innovative test that could improve diagnosis of pediatric urinary tract infections (UTIs) will be discussed today at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo.
Novel Research Sheds Light on Antibody Responses to the SARS-CoV-2 Virus and Vaccines
Two studies presented today at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo reveal how SARS-CoV-2 antibody levels vary among recipients of COVID-19 vaccines and naturally infected individuals. These findings add to a growing body of knowledge that is essential for guiding public health initiatives, and that might one day enable clinicians to assess individuals’ immunity to SARS-CoV-2.
AACC Announces 2022 Corporate Supporter Award Recipients; Thanks Organizations for Their Invaluable Support
AACC is pleased to announce the winners of its 2022 Top Corporate Supporter Awards. This year, AACC recognizes 35 different companies and organizations that generously support the association through advertising, sponsorships, and exhibiting. These significant contributions make it possible for AACC to further its mission of better health through laboratory medicine.
CYTOVALE REVEALS 10-MINUTE, 510(K) PENDING CYTOVALE SYSTEM AND INTELLISEP TEST FOR SEPSIS AT AACC 2022
Cytovale®, a medical diagnostics company focused on providing rapid and insightful tools to improve early detection of fast-moving and immune-mediated diseases, will reveal its 510(k) pending Cytovale system and 10-minute IntelliSep® sepsis risk stratification test at the American Association for Clinical Chemistry (AACC) annual meeting, where new data featuring the test will also be shared. The instrument can be seen in the Cytovale booth, no. 5045, in the exhibit hall during Clinical Lab Expo hours. The IntelliSep test was recently named an AACC Disruptive Technology Award Semifinalist and is also being featured in the Disruptive Tech area of the exhibit hall during the meeting.
Artificial Intelligence in Personalized Medicine, Genomic Sequencing Advances, Human Brain Organogenesis, Building Trust with Patients, Guiding Patient Decisions with Mass Spectrometry, and Much More to Be Explored at 2022 AACC
At the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care.
MESSE DÜSSELDORF TO PROMOTE INTERNATIONAL “MEDICAlliance” PORTFOLIO AT AACC 2022
Messe Düsseldorf will participate in the AACC Clinical Lab Expo 2022 in order to promote its “MEDICAlliance” program of regional and international medical trade fairs organized around the globe.
MEDICA AND COMPAMED 2022 PLANNING ENTERS NEXT STAGE EXHIBITOR REGISTRATION STILL POSSIBLE
The planning for the world’s leading medical trade fair MEDICA 2022 as well as for COMPAMED 2022, the No. 1 trade fair for suppliers of the medical technology industry, has entered the next stage. The current number of exhibitor registrations indicates that participation will surpass last year’s results (MEDICA 2021: 3,033; COMPAMED 2021: 490). Exhibitors can still register online for all segments at www.medica.de/2330 and www.compamed.de/2330 MEDICA and COMPAMED will take place concurrently from November 14 – 17, 2022 at the fairgrounds in Düsseldorf, Germany.